Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6037)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2012 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xu XS, Qu K, Liu C, Zhang YL, Liu J, Song YZ, Zhang P, Liu SN, Chang HL. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma. World J Gastroenterol 2012; 18(48): 7242-7250 [PMID: 23326129 DOI: 10.3748/wjg.v18.i48.7242] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i48/7242.htm |
| Number | Citing Articles |
| 1 |
Zhixin Wang, Kai Qu, Zhichao Huang, Xinsen Xu, Jingyao Zhang, Li Zhang, Sinan Liu, Hulin Chang, Ting Lin, Yamin Liu, Wenquan Niu, Chang Liu. Glutathione S-transferase O2 gene rs157077 polymorphism predicts response to transarterial chemoembolization in hepatocellular carcinoma. Tumor Biology 2015; 36(8): 6463 doi: 10.1007/s13277-015-3336-z
|
| 2 |
Edoardo G. Giannini, Giorgio Sammito, Fabio Farinati, Francesca Ciccarese, Anna Pecorelli, Gian Lodovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Antonio Gasbarrini, Rodolfo Sacco, Francesco Giuseppe Foschi, Gabriele Missale, Filomena Morisco, Gianluca Svegliati Baroni, Roberto Virdone, Franco Trevisani. Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use. Cancer 2014; 120(14): 2150 doi: 10.1002/cncr.28706
|
| 3 |
Lei Liu, Yan Zhao, Jia Jia, Hui Chen, Wei Bai, Man Yang, Zhanxin Yin, Chuangye He, Lei Zhang, Wengang Guo, Jing Niu, Jie Yuan, Hongwei Cai, Jielai Xia, Daiming Fan, Guohong Han. The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization. Scientific Reports 2016; 6(1) doi: 10.1038/srep19851
|
| 4 |
David J. Pinato, Petros Fessas, Antonello Gibbin, Giuseppa Occhino, Elisa Boccato, Carlo Smirne, Rosalba Minisini, Mario Pirisi. T‐cell mediated responses against alpha‐foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival. Liver Cancer International 2021; 2(1): 7 doi: 10.1002/lci2.22
|
| 5 |
Teng Zhang, Wengang Li, Qian Chen, Weiping He, Jing Sun, Dong Li, Quan Wang, Xuezhang Duan. Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1508028
|
| 6 |
Yongqiang Xiao, Wanqing Chen, Wei Deng, Guoqing Zhu, Jin Xie, Laihui Luo, Liucong Lin, Jiahao Tao, Zhigao Hu, Renfeng Shan. Prognostic Value of Alpha-Fetoprotein in Unresectable Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab. Journal of Hepatocellular Carcinoma 2024; : 1251 doi: 10.2147/JHC.S460922
|
| 7 |
Shaoming Song, Mingzhen Bai, Xiaofei Li, Shiyi Gong, Wenwen Yang, Caining Lei, Hongwei Tian, Moubo Si, Xiangyong Hao, Tiankang Guo. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2022; 22(3): 361 doi: 10.1080/14737159.2022.2049248
|
| 8 |
Gauri Mishra, Anouk Dev, Eldho Paul, Wa Cheung, Jim Koukounaras, Ashu Jhamb, Ben Marginson, Beng Ghee Lim, Paul Simkin, Adina Borsaru, James Burnes, Mark Goodwin, Vivek Ramachandra, Manfred Spanger, John Lubel, Paul Gow, Siddharth Sood, Alexander Thompson, Marno Ryan, Amanda Nicoll, Sally Bell, Ammar Majeed, William Kemp, Stuart K. Roberts. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06806-4
|
| 9 |
Andrew X. Zhu, Farshid Dayyani, Chia-Jui Yen, Zhenggang Ren, Yuxian Bai, Zhiqiang Meng, Hongming Pan, Paul Dillon, Shivani K. Mhatre, Vincent E. Gaillard, Sairy Hernandez, Robin Kate Kelley, Bruno Sangro. Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma. Clinical Cancer Research 2022; 28(16): 3537 doi: 10.1158/1078-0432.CCR-21-3275
|
| 10 |
Chao He, Xiaoyun Zhang, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Jiayin Yang, Wusheng Lu. Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization. Oncotarget 2017; 8(49): 85599 doi: 10.18632/oncotarget.20343
|
| 11 |
I-Hsuan Chen, Chien-Chin Hsu, Chee-Chien Yong, Yu-Fan Cheng, Chih-Chi Wang, Chih-Che Lin, Chao-Long Chen. AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation. Cancers 2023; 15(5): 1551 doi: 10.3390/cancers15051551
|
| 12 |
Yan-Zhou Song, Xu Li, Wei Li, Zhong Wang, Kai Li, Fang-Liang Xie, Feng Zhang. Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas. World Journal of Gastroenterology 2018; 24(28): 3145-3154 doi: 10.3748/wjg.v24.i28.3145
|